Skip to main content

Advertisement

Log in

Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the relationship between glaucoma diagnosis and the nailfold capillaroscopy pattern in patients with systemic sclerosis.

Methods

An observational study in a cohort of patients with SSc was conducted. Patients with at least one nailfold videocapillaroscopy and one ophthalmology examination at the same year were included. Data collected were: age, sex; type of systemic sclerosis according to the degree of skin impairment, self-reported ethnicity, disease duration, current use and dosage of systemic corticosteroid, current use and dosage of bosentan®, intraocular pressure, central corneal thickness, diagnosis of glaucoma and capillaroscopy pattern.

Results

Thirty-one patients with systemic sclerosis were enrolled, 23% had glaucoma. There was no statistically significant association between glaucoma diagnosis and the capillaroscopic pattern (p = 0.86). There was also no significant difference (p = 0.66) regarding intraocular pressure between patients with mild (13.9 ± 3.8 mmHg) and severe capillaroscopic pattern (14.4 ± 2.8 mmHg). The odds ratio of glaucoma for severe capillaroscopic pattern compared to mild was 1.6 (95% confidence interval: 0.3–9.5).

Conclusion

Up to 23% of patients with SSc have glaucoma. The high prevalence of glaucoma in SSc suggests a possible systemic vascular disturbance as the cause. However, there seems to be no significant association between the capillaroscopy pattern and glaucoma in systemic sclerosis. Further research is required to improve the understanding of glaucoma in the context of systemic sclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Allanore Y, Avouac J, Wipff J, Kahan A (2007) New therapeutic strategies in the management of systemic sclerosis. Expert Opin Pharmacother 8:607–615

    Article  CAS  PubMed  Google Scholar 

  2. Abraham DJ, Krieg T, Distler J, Distler O (2009) Overview of pathogenesis of systemic sclerosis. Rheumatology 48:3–7

    Article  Google Scholar 

  3. Gomes BA, Santhiago M, Magalhães P, Kara-Junior N, Azevedo M, Moraes HJ (2011) Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo). 66(3):379–385

    Article  Google Scholar 

  4. Allanore Y, Parc C, Monnet D, Brézin A, Kahan A (2004) Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis 63(10):1276–1278

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Yamamoto T, Maeda M, Sawada A, Sugiyama K, Taniguchi T, Kitazawa Y et al (1999) Prevalence of normal-tension glaucoma and primary open-angle glaucoma in patients with collagen diseases. Jpn J Ophthalmol 43(6):539–542

    Article  CAS  PubMed  Google Scholar 

  6. Kitsos G, Tsifetaki N, Gorezis S, Drosos A (2007) Glaucomatous type abnormalities in patients with systemic sclerosis. Clin Exp Rheumatol 25(2):341

    CAS  PubMed  Google Scholar 

  7. Waszczykowska A, Goś R, Waszczykowska E, Dziankowska-Bartkowiak B, Jurowski P (2013) Prevalence of ocular manifestations in systemic sclerosis patients. Arch Med Sci 9(6):1107–1113

    Article  PubMed  PubMed Central  Google Scholar 

  8. Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160

    CAS  PubMed  Google Scholar 

  9. Ghizzoni C, Sebastiani M, Manfredi A, Campomori F, Colaci M, Giuggioli D, Ferri C (2015) Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: clinical and prognostic implications. Microvasc Res 99:92–95

    Article  PubMed  Google Scholar 

  10. Cutolo M, Sulli A, Smith V (2010) Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 6(10):578–587

    Article  PubMed  Google Scholar 

  11. LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205

    CAS  PubMed  Google Scholar 

  12. Cutolo M, Pizzorni C, Sulli A (2005) Capillaroscopy. Best Pract Res Clin Rheumatol 19:437–452

    Article  PubMed  Google Scholar 

  13. Ko-Ming L, Cheng TT, Cheung-Jen C (2009) Clinical applications of nailfold capillaroscopy in different rheumatic diseases. J Intern Med 20:238–247

    Google Scholar 

  14. Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, de Keyser F, Cutolo M (2012) Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann Rheum Dis 71(10):1636–1639

    Article  PubMed  Google Scholar 

  15. Leske MC (2009) Ocular perfusion pressure and glaucoma: clinical trial and epidemiological findings. Curr Opin Ophthalmol 20(2):73–78

    Article  PubMed  PubMed Central  Google Scholar 

  16. Emre M, Orgul S, Gugleta K et al (2004) Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation. Br J Ophthalmol 88:662–666

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Tailor R, Gupta A, Herrick A, Kwartz J (2009) Ocular manifestations of scleroderma. Surv Ophthalmol 54(2):292–304

    Article  PubMed  Google Scholar 

  18. Balbir-Gurman A, Braun-Moscovici Y (2012) Scleroderma—new aspects in pathogenesis and treatment. Best Pract Res Clin Rheumatol 26:13–24

    Article  CAS  PubMed  Google Scholar 

  19. Hasegawa M (2016) Biomarkers in systemic sclerosis: their potential to predict clinical courses. J Dermatol 43(1):29–38

    Article  CAS  PubMed  Google Scholar 

  20. Cabral-Marques O, Riemekasten G (2016) Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis. Autoimmun Rev 15(7):690–694

    Article  CAS  PubMed  Google Scholar 

  21. Polak K, Luksch A, Frank B, Jandrasits K, Polska E, Schmetterer L (2003) Regulation of human retinal blood flow by endothelin-1. Exp Eye Res 76:633–640

    Article  CAS  PubMed  Google Scholar 

  22. Resch H, Karl K, Weigert G, Wolzt M, Hommer A, Schmetterer L, Garhöfer G (2009) Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci 50(1):358–363

    Article  PubMed  Google Scholar 

  23. Yorio T, Krishnamoorthy R, Prasanna G (2002) Endothelin: is it a contributor to glaucoma pathophysiology? J Glaucoma 11:259–270

    Article  PubMed  Google Scholar 

  24. Dismuke WM, Liang J, Overby DR, Stamer WD (2014) Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility. Exp Eye Res 120:28–35

    Article  CAS  PubMed  Google Scholar 

  25. Emre S, Kayikçioğlu O, Ateş H, Cinar E, Inceoğlu N, Yargucu F, Pirildar T, Oksel F (2010) Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the reichert ocular response analyzer. Cornea 29(6):628–631

    Article  PubMed  Google Scholar 

  26. Shih CY, Graff Zivin JS, Trokel SL et al (2004) Clinical significance of central corneal thickness in the management of glaucoma. Arch Ophthalmol 122:1270–1275

    Article  PubMed  Google Scholar 

  27. Serup L, Serup J, Hagdrup H (1984) Increased central cornea thickness in systemic sclerosis. Acta Ophthalmol (Copenh) 62(1):69–74

    Article  CAS  Google Scholar 

  28. Gomes BA, Santhiago M, Kara-Junior N et al (2011) Central corneal thickness in patients with systemic sclerosis: a controlled study. Cornea 30(10):1125–1128

    Article  Google Scholar 

  29. Gomes BA, Santhiago MR, Kara-Junior N, de Azevedo MN, Moraes HV Jr (2015) Assessment of central corneal thickness in different subtypes of systemic sclerosis. Ocul Immunol Inflamm 11:1–6

    Google Scholar 

  30. Atik SS, Koc F, Sari SA, Yurdakul NS, Ozmen M, Akar S (2015) Anterior segment parameters and eyelids in systemic sclerosis. Int Ophthalmol 36(4):577–583

    Article  Google Scholar 

  31. Garbe E, LeLorier J, Boivin JF et al (1997) Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet 350:979–982

    Article  CAS  PubMed  Google Scholar 

  32. Iudici M, van der Goes MC, Valentini G, Bijlsma JW (2013) Glucocorticoids in systemic sclerosis: weighing the benefits and risks—a systematic review. Clin Exp Rheumatol 31(2 Suppl 76):157–165

    PubMed  Google Scholar 

  33. Gomes BF, Moraes HV Jr, Kara-Junior N, de Azevedo MN, de Lima FBF, Santhiago MR (2014) Intraocular pressure in chronic users of low-dose oral corticosteroids for connective tissue disease. Can J Ophthalmol 49(4):363–366

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beatriz Fiuza Gomes.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gomes, B.F., Souza, R., Valadão, T. et al. Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?. Int Ophthalmol 38, 251–256 (2018). https://doi.org/10.1007/s10792-017-0454-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-017-0454-1

Keywords

Navigation